Showing results (111-120 of 250) with videos related to
Sort By:
Pageof 25
Environmental Research|December 1, 1985
Pleural calcification in northwest GreeceT Bazas, D Oakes, J C Gilson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001
Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trialS A Factor, J H Friedman, M C Lannon, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 12, 2017
Cannabinoids Activate Monoaminergic Signaling to Modulate Key C. elegans BehaviorsMitchell D Oakes, Wen Jing Law, Tobias Clark, et al.Neurology|August 5, 2009
Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participantsK Marder, H Zhao, S Eberly, et al.Plos One|August 3, 2018
Uptake and tissue accretion of orally administered free carboxylic acid as compared to ethyl ester form of docosahexaenoic acid (DHA) in the ratAnna Lindblom, Cecilia Ericsson, Therese Hagstedt, et al.Journal of Pediatric Surgery|December 1, 1992
Pyloric stenosis in a premature infantB C Cosman, A E Sudekum, D D Oakes, et al.Analytical Chemistry|July 21, 2011
Solid-phase microextraction coupled to LC-ESI-MS/MS: evaluation and correction for matrix-induced ionization suppression/enhancement for pharmaceutical analysis in biological and environmental samplesXu Zhang, Ken D Oakes, Di Luong, et al.Neurology|May 10, 2006
Safety of rasagiline in elderly patients with Parkinson diseaseC G Goetz, S R Schwid, S W Eberly, et al.Journal of Separation Science|December 21, 2012
Development and evaluation of a new in vivo solid-phase microextraction samplerOluranti P Togunde, Heather Lord, Ken D Oakes, et al.Clinical Genetics|October 15, 2016
Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS)K A Quaid, S W Eberly, E Kayson-Rubin, et al.Pageof 25